Form 4: Inogen CEO Smith Reports RSU Vesting, Tax-Related Stock Sale

Inogen Inc.'s CEO and President, Kevin Raymond Smith, reported the vesting of 28,334 restricted stock units and a subsequent sale of 13,817 shares to cover tax obligations.

Summary

• Kevin Raymond Smith, CEO and President of Inogen Inc., reported transactions on December 1, 2025, under a Rule 10b5-1 plan.
• 28,334 restricted stock units (RSUs) vested and converted into common stock.
• 13,817 shares of common stock were disposed of at a price of $6.95 per share to cover tax withholding liabilities associated with the RSU vesting.
• Following these transactions, Smith's direct beneficial ownership of common stock is 86,291 shares.
• Smith continues to hold 28,333 unvested restricted stock units, which are subject to a vesting schedule of 1/3rd annually from December 1, 2023.

Sentiment

Score: 6

Explanation: Neutral to slightly positive. The transaction is routine and expected, reflecting the execution of an existing compensation plan. The vesting of RSUs is a positive for executive alignment, while the tax-related sale is a standard, non-discretionary event.

Positives

• The vesting of 28,334 restricted stock units demonstrates the execution of a long-term incentive plan, aligning the CEO's interests with shareholders.
• The transaction was made pursuant to a Rule 10b5-1 plan, indicating a pre-scheduled and non-discretionary event.

Negatives

• A portion of the vested shares, 13,817, was sold to cover tax liabilities, resulting in a reduction of the CEO's direct common stock holdings.

Future Outlook

The filing indicates a future vesting schedule for the remaining 28,333 restricted stock units, with 1/3rd vesting annually from December 1, 2023, subject to the reporting person's continued service.

Industry Context

This Form 4 filing is a routine disclosure of an insider transaction, reflecting standard executive compensation practices involving equity awards. It does not provide broader industry-specific context or trends.

Comparison to Industry Standards

• The vesting of restricted stock units and subsequent sale of shares to cover tax obligations is a common and standard practice in executive compensation across various industries, aligning with typical equity incentive structures.
• The use of a Rule 10b5-1 plan for these transactions is also a standard corporate governance practice designed to provide an affirmative defense against insider trading allegations.

Corporate Governance

Related Party Transactions

• The transaction involves the CEO and the company's equity, which is a standard related-party transaction within the scope of executive compensation.

Stakeholder Impact

• Shareholders: Provides transparency regarding insider stock ownership and compensation, confirming the execution of pre-approved equity awards.
• Management: The CEO's compensation structure is being executed as planned, with a portion of equity awards vesting and a standard tax-related sale.

Next Steps

• Future vesting of the remaining 28,333 restricted stock units will occur annually from December 1, 2023, subject to continued service.

Key Dates

Recommendation

This Form 4 filing details a routine insider transaction involving the vesting of restricted stock units and a subsequent tax-related sale. Such transactions are typically pre-scheduled and non-discretionary, providing transparency into executive compensation but rarely indicating a change in the company's fundamental outlook or warranting a change in investment recommendation. The CEO's continued holding of a significant number of shares and unvested RSUs suggests ongoing alignment with shareholder interests. Therefore, a 'hold' recommendation is appropriate as this filing does not present new information that would alter the investment thesis.

Keywords

Inogen Inc, INGN, Kevin Raymond Smith, CEO, President, Form 4, SEC filing, insider transaction, restricted stock units, RSU vesting, stock sale, tax withholding, beneficial ownership, Rule 10b5-1